In a new podcast series looking specifically at Bruegel research, Zsolt Darvas expounds on the themes of a research paper he has co-written on the macroeconomic implications of healthcare.
Health-care systems play a crucial role in supporting human health. They also have major macroeconomic implications, an aspect that is not always properly acknowledged. Using a standard method to measure efficiency, data envelopment analysis (DEA), the authors find significant differences between countries. This finding calls for policy responses.
What are the strengths and challenges of health care systems in each EU country? What are the common policy priorities and opportunities for EU value added?What role do healthcare systems play in public finances and macroeconomic developments? What are the economic values of investing in healthcare?
Healthcare reform has been a thorn in the side of the US administration for several months, prompting President Trump to declare that “Nobody knew that healthcare could be so complicated.” We review recent economists’ views on the issue.
What’s at stake: The US Department of Health and Human Services (HHS) declares that the country is “in the midst of an unprecedented opioid epidemic”. Since 1999, the rate of overdose deaths involving opioids - including prescription pain relievers and heroin - nearly quadrupled. We review contributions looking at the economic drivers and implications of this phenomenon.
Pathological microbes are increasingly resistant to antimicrobial treatments. The resulting health crisis is one of the greatest challenges facing society. At this event, Jim O'Neill will present the Independent Review on Antimicrobial Resistance and a panel will discuss how to tackle drug resistance.
The EU health sector represents 10% of GDP, 15% of public expenditure and 8% of the workforce, and has high potential for innovation and growth. Improvements in people's health impact productivity, labour supply, employability and workforce mobility.
Near universal access to quality healthcare is an emblem of the "European model", but how can we ensure the sustainability of EU healthcare systems in an era of aging populations and budget restraint? Do innovation and more effective measurement of outcomes offer a way forward?
Japan is the most rapidly aging country in the world. A total reform of the Japanese social security system, therefore, is inevitable. Other advanced economies could learn from the Japanese experience.